Home Compliance OIG Permits Medical Device Manufacturer’s Cost-Sharing Subsidies for Medicare Beneficiaries in Clinical... ComplianceExpert OpinionFCA OIG Permits Medical Device Manufacturer’s Cost-Sharing Subsidies for Medicare Beneficiaries in Clinical Trial February 2, 2024 9 Share FacebookLinkedinTwitter Gorodenkoff | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Expert Opinion The Next Frontier: Key Takeaways from the New U.S. Government Commercial Space Strategies Compliance Not an April Fools Joke – FAR Part 40 Final Rule Has Been Published Compliance A High-Level Overview of the Regulatory Scheme Under the NPRM